eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN

Abstract Extensive efforts have now characterized the somatic molecular alterations in human breast cancer (Cancer Genome Atlas Network, 2012; Stephens et al, 2012) and have led to a re‐definition of the disease as a constellation of 10 distinct driver‐based subtypes (IntClust subtypes) (Curtis et a...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hege G Russnes, Carlos Caldas
Formato: Artigo
Idioma:English
Publicado em: Springer Nature 2014-12-01
coleção:EMBO Molecular Medicine
Acesso em linha:https://doi.org/10.15252/emmm.201404683